Clinical and Radiographic Outcomes of the JointMedica Polymotion Resurfacing (PHR) Device

Launched by JOINTMEDICA INC. · Jul 15, 2025

Keywords

ClinConnect Summary

This clinical study is looking at how well the Polymotion Hip Resurfacing (PHR) device works for people who have had it implanted to treat hip osteoarthritis, a condition that causes hip pain and stiffness. The researchers want to see how long the device lasts, how well it stays in place as seen on X-rays, if patients need any additional hip surgeries, whether there are any serious problems related to the device, and how patients feel about their hip function and pain after surgery.

People who might join the study are those aged 21 or older who had the Polymotion Hip Resurfacing device implanted between September 2020 and January 2025. There are no specific reasons to exclude anyone who fits these criteria. Participants will be followed for up to two years, during which their hip will be checked with X-rays and they will be asked to complete simple questionnaires about their hip health and ability to move. This study is not yet recruiting participants but aims to gather real-world information to better understand the safety and effectiveness of this hip device.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 21 or above at the time of the surgery.
• • Have had the Polymotion Hip Resurfacing (PHR) (implanted between September 2020 to January 2025
• • Written informed consent given by subject
• Exclusion Criteria:
• • There is no exclusion criteria for this study